123 related articles for article (PubMed ID: 19007046)
1. Effect of liver and kidney function on migafungin disposition in patients with hematologic malignancies.
Nakagawa Y; Ichii Y; Saeki Y; Kodama M; Kishino S; Suzuki K
Eur J Drug Metab Pharmacokinet; 2008; 33(3):191-8. PubMed ID: 19007046
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentration of micafungin in patients with hematologic malignancies.
Nakagawa Y; Ichii Y; Saeki Y; Kodaka M; Suzuki K; Kishino S
J Infect Chemother; 2007 Feb; 13(1):39-45. PubMed ID: 17334728
[TBL] [Abstract][Full Text] [Related]
3. Penetration of micafungin into the burn eschar in patients with severe burns.
Sasaki J; Yamanouchi S; Sato Y; Abe S; Shinozawa Y; Kishino S; Aikawa N; Hori S
Eur J Drug Metab Pharmacokinet; 2014 Jun; 39(2):93-7. PubMed ID: 23771854
[TBL] [Abstract][Full Text] [Related]
4. The impact of total bilirubin on plasma micafungin levels in living-donor liver transplantation recipients with severe liver dysfunction.
Muraki Y; Iwamoto T; Kagawa Y; Sakurai H; Usui M; Isaji S; Uemoto S; Okuda M
Biol Pharm Bull; 2009 Apr; 32(4):750-4. PubMed ID: 19336919
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of micafungin in patients undergoing allogeneic hematopoietic stem cell transplantation.
Oshima K; Kanda Y; Kako S; Ohno K; Kishino S; Kurokawa M
Transpl Infect Dis; 2013 Jun; 15(3):323-7. PubMed ID: 23578224
[TBL] [Abstract][Full Text] [Related]
6. Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
Yoshikawa K; Nakazawa Y; Katsuyama Y; Hirabayashi K; Saito S; Shigemura T; Tanaka M; Yanagisawa R; Sakashita K; Koike K
Infection; 2014 Aug; 42(4):639-47. PubMed ID: 24567233
[TBL] [Abstract][Full Text] [Related]
7. Distribution of micafungin in the tissue fluids of patients with invasive fungal infections.
Yamada N; Kumada K; Kishino S; Mochizuki N; Ohno K; Ogura S
J Infect Chemother; 2011 Oct; 17(5):731-4. PubMed ID: 21537970
[TBL] [Abstract][Full Text] [Related]
8. [A liquid chromatographic method for quantifying unbound micafungin in human plasma and the relationship between the concentrations of unbound and total micafungin in plasma].
Noda K; Yokoyama T; Akiyama Y; Tadano K
Yakugaku Zasshi; 2013; 133(3):397-404. PubMed ID: 23208119
[TBL] [Abstract][Full Text] [Related]
9. Micafungin concentrations in the plasma and burn eschar of severely burned patients.
Sasaki J; Yamanouchi S; Kudo D; Endo T; Nomura R; Takuma K; Kushimoto S; Shinozawa Y; Kishino S; Hori S; Aikawa N
Antimicrob Agents Chemother; 2012 Feb; 56(2):1113-5. PubMed ID: 22083486
[TBL] [Abstract][Full Text] [Related]
10. Impact of plasma exchange on pharmacokinetic disposition of micafungin.
Konishi H; Fukushima K; Saotome T; Hamamoto T; Eguchi Y; Sudo M; Sumi M; Minouchi T; Iga I; Yamaji A
Ther Apher Dial; 2010 Jun; 14(3):358-63. PubMed ID: 20609192
[TBL] [Abstract][Full Text] [Related]
11. Effect of blood decrease on micafungin disposition in rats.
Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Yamaji A
Eur J Drug Metab Pharmacokinet; 2011 Mar; 36(1):35-9. PubMed ID: 21350921
[TBL] [Abstract][Full Text] [Related]
12. Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.
Mehta PA; Vinks AA; Filipovich A; Bleesing J; Jodele S; Jordan MB; Marsh R; Tarin R; Edwards S; Fearing D; Lawrence J; Davies SM
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1458-62. PubMed ID: 20546908
[TBL] [Abstract][Full Text] [Related]
13. Reduced elimination clearance of micafungin in rats with cholestatic hyperbilirubinemia.
Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Takada K; Yamaji A
Fundam Clin Pharmacol; 2010 Aug; 24(4):457-62. PubMed ID: 19845766
[TBL] [Abstract][Full Text] [Related]
14. A comparative analysis of micafungin and caspofungin for empirical antifungal therapy in antibiotic-unresponsive febrile patients with hematologic malignancies.
Seko T; Usami E; Kimura M; Nakao T; Matsuoka T; Yoshimura T; Kanamori N; Tachi T; Teramachi H
Pharmazie; 2016 Aug; 71(8):484-488. PubMed ID: 29442037
[TBL] [Abstract][Full Text] [Related]
15. Ocular distribution of intravenously administered micafungin in rabbits.
Suzuki T; Uno T; Chen G; Ohashi Y
J Infect Chemother; 2008 Jun; 14(3):204-7. PubMed ID: 18574655
[TBL] [Abstract][Full Text] [Related]
16. Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients.
Walsh TJ; Goutelle S; Jelliffe RW; Golden JA; Little EA; DeVoe C; Mickiene D; Hayes M; Conte JE
Antimicrob Agents Chemother; 2010 Aug; 54(8):3451-9. PubMed ID: 20439610
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of micafungin for treating febrile neutropenia in hematological malignancies.
Goto N; Hara T; Tsurumi H; Ogawa K; Kitagawa J; Kanemura N; Kasahara S; Yamada T; Shimizu M; Nakamura M; Matsuura K; Moriwaki H
Am J Hematol; 2010 Nov; 85(11):872-6. PubMed ID: 20882524
[TBL] [Abstract][Full Text] [Related]
18. Bronchopulmonary disposition of micafungin in healthy adult volunteers.
Nicasio AM; Tessier PR; Nicolau DP; Knauft RF; Russomanno J; Shore E; Kuti JL
Antimicrob Agents Chemother; 2009 Mar; 53(3):1218-20. PubMed ID: 19114675
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the blood level of micafungin involving patients with hematological diseases: new findings regarding combination therapy with tacrolimus.
Shimoeda S; Ohta S; Kobayashi H; Saitou H; Kubota A; Yamato S; Shimada K; Sasaki M; Kawano K
Biol Pharm Bull; 2005 Mar; 28(3):477-80. PubMed ID: 15744072
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of micafungin for febrile neutropenia in pediatric patients with hematological malignancies: a multicenter prospective study.
Kobayashi R; Suzuki N; Yoshida M; Iizuka S; Suzuki D; Sano H; Kudoh T
J Pediatr Hematol Oncol; 2013 Oct; 35(7):e276-9. PubMed ID: 23743960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
